BE864726A - Compositions pharmaceutiques contenant de la cholestyramine - Google Patents

Compositions pharmaceutiques contenant de la cholestyramine

Info

Publication number
BE864726A
BE864726A BE6046383A BE6046383A BE864726A BE 864726 A BE864726 A BE 864726A BE 6046383 A BE6046383 A BE 6046383A BE 6046383 A BE6046383 A BE 6046383A BE 864726 A BE864726 A BE 864726A
Authority
BE
Belgium
Prior art keywords
pharmaceutical compositions
compositions containing
containing cholestyramine
cholestyramine
pharmaceutical
Prior art date
Application number
BE6046383A
Other languages
English (en)
Inventor
R S Todd
G R Fryers
Original Assignee
Reckitt & Colmann Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reckitt & Colmann Prod Ltd filed Critical Reckitt & Colmann Prod Ltd
Publication of BE864726A publication Critical patent/BE864726A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE6046383A 1977-03-10 1978-03-09 Compositions pharmaceutiques contenant de la cholestyramine BE864726A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB10133/77A GB1566609A (en) 1977-03-10 1977-03-10 Pharmaceutical compositions containing cholestyramine and alginic acid

Publications (1)

Publication Number Publication Date
BE864726A true BE864726A (fr) 1978-09-11

Family

ID=9962124

Family Applications (1)

Application Number Title Priority Date Filing Date
BE6046383A BE864726A (fr) 1977-03-10 1978-03-09 Compositions pharmaceutiques contenant de la cholestyramine

Country Status (14)

Country Link
US (1) US4172120A (fr)
JP (1) JPS53113007A (fr)
AU (1) AU518596B2 (fr)
BE (1) BE864726A (fr)
CA (1) CA1087986A (fr)
CH (1) CH647949A5 (fr)
DE (1) DE2810250A1 (fr)
FR (1) FR2382893A1 (fr)
GB (1) GB1566609A (fr)
IE (1) IE46479B1 (fr)
IT (1) IT7867510A0 (fr)
NL (1) NL7802588A (fr)
NZ (1) NZ186656A (fr)
ZA (1) ZA781398B (fr)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4439419A (en) * 1980-02-20 1984-03-27 The Upjohn Company Method of treating gastric hyperacidity in humans employing a copolymer of polyethylenepolyamine and a bifunctional substance as epichlorhydrin
US4414198A (en) * 1982-04-23 1983-11-08 Joseph Michaelson Rapidly disintegrable tablet composition and method
US4797288A (en) * 1984-10-05 1989-01-10 Warner-Lambert Company Novel drug delivery system
US4828857A (en) * 1984-10-05 1989-05-09 Warner-Lambert Company Novel sweetener delivery systems
US4804548A (en) * 1984-10-05 1989-02-14 Warner-Lambert Company Novel sweetener delivery systems
US4843098A (en) * 1985-02-05 1989-06-27 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4818539A (en) * 1985-02-05 1989-04-04 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4747881A (en) * 1985-02-05 1988-05-31 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4851392A (en) * 1985-02-05 1989-07-25 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4790991A (en) * 1985-02-05 1988-12-13 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4778676A (en) * 1985-12-20 1988-10-18 Warner-Lambert Company Confectionery delivery system for actives
WO1987004077A1 (fr) * 1986-01-03 1987-07-16 The University Of Melbourne Composition contre les reflux gastro-oesophagiens
JPS62195323A (ja) * 1986-02-24 1987-08-28 Eisai Co Ltd 胃内滞留型粒子
IT1190349B (it) * 1986-06-16 1988-02-16 Prodotti Formenti Srl Composizioni farmaceutiche ad attivita' sequestrante degli acidi biliari contenenti colestiramina quale principio attivo,e procedimento per prepararle
US5167965A (en) * 1987-02-09 1992-12-01 The Dow Chemical Company Palatable cholestyramine granules, tablets and methods for preparation thereof
US4837255A (en) * 1987-03-10 1989-06-06 Ciba-Geigy Corporation Palatable hypocholesterolaemic gel formulation containing a pharmaceutically acceptable non-digestible anion exchange resin
US5910317A (en) * 1988-01-11 1999-06-08 The Procter & Gamble Company Mixed compositions for treating hypercholesterolemia
DE3808191C2 (de) * 1988-03-11 1998-08-06 Astra Chem Gmbh Colestyramin enthaltende pharmazeutische Zusammensetzung
US5096714A (en) * 1988-06-28 1992-03-17 Hauser-Kuhrts, Inc. Prolonged release drug tablet formulations
CA2002492A1 (fr) * 1988-11-11 1990-05-11 Sandra T. A. Malkowska Compose pharmaceutique contenant une resine echangeuse d'ions
IL95574A (en) 1989-09-09 1994-11-11 Knoll Ag Colestyramine preparation
DE3935550A1 (de) * 1989-10-25 1991-05-02 Pharmatrans Sanaq Ag Kaubare oder lutschbare arzneiform, verfahren zu ihrer herstellung und ihre verwendung
FR2664499B1 (fr) * 1990-07-16 1994-11-04 Jacques Dubois Nouvelles formes pharmaceutiques, leur procede de preparation et leurs applications.
EP0484106A1 (fr) * 1990-11-01 1992-05-06 Merck & Co. Inc. Compositions à libération contrôlée
US5166137A (en) * 1991-03-27 1992-11-24 Nobipols Forskningsstiftelse Guluronic acid polymers and use of same for inhibition of cytokine production
US5380522A (en) * 1992-08-11 1995-01-10 Day; Charles E. Method for treatment of irritable bowel syndrome
US5422101A (en) * 1993-05-14 1995-06-06 The Procter & Gamble Company Cholesterol lowering drink mix compositions
GB9322314D0 (en) * 1993-10-29 1993-12-15 Scherer Ltd R P Foam generating capsules
US5705190A (en) * 1995-12-19 1998-01-06 Abbott Laboratories Controlled release formulation for poorly soluble basic drugs
US5980882A (en) * 1997-04-16 1999-11-09 Medeva Pharmaceuticals Manufacturing Drug-resin complexes stabilized by chelating agents
PL194696B1 (pl) * 1997-04-30 2007-06-29 Reckitt Benckiser Healthcare Kompozycja w stałej postaci dawkowania zawierająca alginiany
GB9708773D0 (en) * 1997-04-30 1997-06-25 Reckitt & Colmann Prod Ltd Organic compositions
US6733780B1 (en) 1999-10-19 2004-05-11 Genzyme Corporation Direct compression polymer tablet core
GB0012094D0 (en) * 2000-05-19 2000-07-12 Reckitt & Colmann Prod Ltd Pharmaceutical compositions
US7985418B2 (en) 2004-11-01 2011-07-26 Genzyme Corporation Aliphatic amine polymer salts for tableting
GB0515492D0 (en) * 2005-07-28 2005-08-31 Reckitt Benckiser Healthcare Improvements in or relating to compositions,articles and methods
CN103027896B (zh) * 2005-09-15 2016-01-20 基酶有限公司 胺聚合物的小袋制剂
WO2008080092A2 (fr) * 2006-12-22 2008-07-03 Ironwood Pharmaceuticals, Inc. Méthodes et compositions pour le traitement de troubles oesophagiens
US20110129433A1 (en) * 2008-06-26 2011-06-02 Ironwood Pharmaceuticals, Inc. Compositions and Methods for Treating or Preventing Gastrointestinal Disorders and GERD-Related Respiratory Disorders
EP2352568B1 (fr) * 2008-10-02 2017-11-29 University of Pittsburgh - Of the Commonwealth System of Higher Education Administration d'un polymère adsorbant pour le traitement d'une inflammation systémique
AU2011242177B8 (en) * 2010-04-23 2015-06-04 S-Biotek Holding Aps A solid pharmaceutical composition for neutralizing stomach acid
MX366925B (es) 2010-11-04 2019-07-31 Albireo Ab Inhibidores de ibat para el tratamiento de enfermedades hepaticas.
US20130236541A1 (en) 2010-11-08 2013-09-12 Albireo Ab Pharmaceutical combination comprising an ibat inhibitor and a bile acid binder
EA038594B1 (ru) 2011-10-28 2021-09-21 Шайр Хьюман Дженетик Терапис, Инк. Ингибиторы рециркуляции желчных кислот для лечения гиперхолемии и холестатического заболевания печени
JP6217938B2 (ja) 2011-10-28 2017-10-25 ルメナ ファーマシューティカルズ エルエルシー 小児の胆汁うっ滞性肝疾患の処置のための胆汁酸再循環阻害剤
FR2994387B1 (fr) * 2012-08-13 2016-07-29 Basf Beauty Care Solutions France Sas Ingredient hydratant cosmetique ou pharmaceutique
AU2014229050A1 (en) 2013-03-15 2015-10-22 Lumena Pharmaceuticals Llc Bile acid recycling inhibitors for treatment of Barrett's esophagus and gastroesophageal reflux disease
KR20160002773A (ko) 2013-03-15 2016-01-08 루메나 파마수티컬즈, 인코포레이티드 원발성 담관염 및 염증성 장 질환 치료용 담즙산 재순환 억제제
US20160129025A1 (en) * 2013-07-15 2016-05-12 Chengzhi Life Science., Ltd. Anti-fatigue composition and use thereof
CA2952406A1 (fr) 2014-06-25 2015-12-30 Ea Pharma Co., Ltd. Preparation solide et procede d'inhibition ou d'attenuation de coloration de celle-ci
EP3012252A1 (fr) 2014-10-24 2016-04-27 Ferring BV Formes crystallines d'Elobixibat
US10245284B2 (en) 2015-08-19 2019-04-02 Alpex Pharma S.A. Granular composition for oral administration
JP6954927B2 (ja) 2016-02-09 2021-10-27 アルビレオ・アクチボラグ 経口コレスチラミン製剤及びその使用
CA3011595C (fr) 2016-02-09 2024-01-02 Albireo Ab Pastilles de cholestyramine et procedes de preparation associes
CN108601744B (zh) 2016-02-09 2022-01-04 阿尔比里奥公司 口服考来烯胺制剂及其用途
CN111032019B (zh) 2017-08-09 2022-07-05 阿尔比里奥公司 考来烯胺颗粒、口服考来烯胺制剂及其用途
JP7391048B2 (ja) 2018-06-05 2023-12-04 アルビレオ・アクチボラグ ベンゾチア（ジ）アゼピン化合物及び胆汁酸モジュレータとしてのそれらの使用
KR20210024033A (ko) 2018-06-20 2021-03-04 알비레오 에이비 오데빅시바트의 약학 제제
US11549878B2 (en) 2018-08-09 2023-01-10 Albireo Ab In vitro method for determining the adsorbing capacity of an insoluble adsorbant
US10722457B2 (en) 2018-08-09 2020-07-28 Albireo Ab Oral cholestyramine formulation and use thereof
US11007142B2 (en) 2018-08-09 2021-05-18 Albireo Ab Oral cholestyramine formulation and use thereof
EP4424363B1 (fr) 2019-02-12 2026-04-29 Mirum Pharmaceuticals, Inc. Procédés pour augmenter la croissance chez des sujets pédiatriques présentant une maladie hépatique cholestatique

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK106457C (da) 1962-01-23 1967-02-06 Ernst Helmer Hagstam Røntgenkontrastmiddel med lille massefylde og fremgangsmåde til dets fremstilling.
DE1195213B (de) * 1963-06-12 1965-06-16 Dynamit Nobel Ag Zuendladung fuer zuendunwillige Sprengstoffe
US3499960A (en) * 1965-01-25 1970-03-10 Merck & Co Inc Palatable coated particles of an anion exchange resin
US3769399A (en) * 1971-03-05 1973-10-30 L Hagerman Intestinal bile acid binding process and compositions
US3974272A (en) * 1972-09-01 1976-08-10 Merck & Co., Inc. Palatable cholestyramine coacervate compositions
GB1509866A (en) * 1975-06-10 1978-05-04 Johnson & Johnson Enteric coated digestive enzyme compositions

Also Published As

Publication number Publication date
ZA781398B (en) 1979-02-28
NZ186656A (en) 1979-06-19
FR2382893B1 (fr) 1981-07-10
AU3396978A (en) 1979-09-13
DE2810250A1 (de) 1978-09-14
NL7802588A (nl) 1978-09-12
GB1566609A (en) 1980-05-08
AU518596B2 (en) 1981-10-08
US4172120A (en) 1979-10-23
CA1087986A (fr) 1980-10-21
IE780486L (en) 1978-09-10
FR2382893A1 (fr) 1978-10-06
IT7867510A0 (it) 1978-03-09
IE46479B1 (en) 1983-06-29
JPS53113007A (en) 1978-10-03
CH647949A5 (de) 1985-02-28

Similar Documents

Publication Publication Date Title
SE7810591L (sv) Farmaceutiska kompositioner
BE872319A (fr) Composition pharmaceutique
BE873973A (fr) Derives de metronidazole et compositions pharmaceutiques en contenant
BE866568A (fr) Compositions therapeutiques contenant des derives de d,1-carnitine et leur utilisation
BE851590A (fr) Compositions pharmaceutiques renfermant des pyrethrinoides
BE877393A (fr) Phenethanolamines et compositions pharmaceutiques en contenant
ZA781398B (en) Pharmaceutical compositions
FR2347365A1 (fr) Trans-hexahydro-pyrido-indoles, leur preparation et compositions pharmaceutiques les contenant
BE864359A (fr) Compositions pharmaceutiques antioestrogenes
IT1095377B (it) Composizione farmaceutica
ATA53978A (de) Insektizides mittel
BE826935A (fr) Compositions pharmaceutiques antivirales
ATA9378A (de) Insektizides mittel
IT1111453B (it) Composizione germicida
IT7849938A0 (it) Composizioni farmaceutiche
FR2460136B1 (fr) Compositions pharmaceutiques contenant des extraits de lierre grimpant
SE7806441L (sv) Lekemedelskomposition
BE870265A (fr) Compositions pharmaceutiques anti-inflammatoires
DK461579A (da) Farmeceutisk komposition indeholdende en aryltrifluorethanol
NL7801464A (nl) Farmaceutische samenstellingen.
FR2340310A1 (fr) Hydrazinophtalazines substituees, leur preparation et compositions pharmaceutiques les contenant
FR2310132A1 (fr) 14b-hydroxy-3-desoxycardenolides et analogues de ceux-ci, leur preparation et compositions pharmaceutiques les contenant
SE7602128L (sv) Legerinskompositioner
FR2609392B1 (fr) Compositions pharmaceutiques contenant des pyranoquinoleines
FI781507A7 (fi) Farmaceutiska kompositioner

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: RECKITT & COLMAN PRODUCTS LTD

Effective date: 19850309